Immediate Impact
1 by Nobel laureates 75 standout
Citing Papers
Deuterium in drug discovery: progress, opportunities and challenges
2023 Standout
Novel approaches for vaccine development
2021 Standout
Works of Rajeev Kumar being referenced
Deutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia (AIM-TD): a double-blind, randomised, placebo-controlled, phase 3 trial
2017
Polio-free certification and lessons learned--South-East Asia region, March 2014.
2014
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Rajeev Kumar | 466 | 57 | 35 | 235 | 162 | 49 | 1.1k | |
| Badhin Gómez | 668 | 11 | 363 | 418 | 36 | 1.2k | ||
| Gregory L. McIntire | 124 | 19 | 27 | 91 | 22 | 52 | 978 | |
| Paul Gordon | 176 | 39 | 157 | 35 | 6 | 68 | 1.2k | |
| Yuming Lai | 611 | 46 | 21 | 35 | 23 | 45 | 1.2k | |
| G. García | 542 | 145 | 22 | 21 | 55 | 67 | 1.2k | |
| Lingzhi Ma | 642 | 15 | 43 | 374 | 33 | 70 | 1.4k | |
| D. Powell | 208 | 10 | 88 | 170 | 6 | 70 | 1.2k | |
| Xueguo Liu | 241 | 3 | 2 | 212 | 13 | 54 | 1.2k | |
| Matteo Briganti | 754 | 5 | 84 | 52 | 38 | 1.2k | ||
| Katsuo Takahashi | 388 | 20 | 3 | 117 | 9 | 98 | 967 |
All Works
Login with ORCID to disown or claim papers
Loading papers...